Get the Daily Brief
Latest Biotech News
Cancer research innovations identify metabolic and molecular targets
Groundbreaking studies reveal novel molecular mechanisms and metabolic vulnerabilities in cancer. Discoveries include new enzyme families degrading bacterial carbohydrates, emerging tumor energy...
Gene editing and molecular biology breakthroughs enhance therapeutic potential
Recent advances include enhancement of CRISPR-Cas9 gene editing precision by inducing autophagy to shift DNA repair toward homologous recombination, increasing accuracy of genome modifications....
Precision oncology advances: CAR-T therapies targeting novel antigens and therapy resistance
Cutting-edge cancer therapeutics include innovative CAR-T cell designs targeting solid tumors through molecular targets like Eva1, enhancing immune synapse formation and cytotoxicity....
Recursion Pharmaceuticals reduces workforce amid funding challenges
Recursion Pharmaceuticals, an AI-driven biopharmaceutical company, announced layoffs affecting 20% of its staff as part of organizational streamlining and pipeline pruning. This step follows...
AI and machine learning accelerate biotech discovery and target identification
Artificial intelligence is reshaping life sciences by enabling faster hypothesis generation, target discovery, and biomarker identification. Leading firms and scientific teams deploy advanced AI...
FDA approval shakes up pediatric RSV treatment amid CDC upheaval
Merck has gained FDA approval for Enflonsia (clesrovimab), a monoclonal antibody for preventing respiratory syncytial virus (RSV) lower respiratory tract disease in infants. This entry intensifies...
Recursion cuts 20% of staff amid funding and pipeline challenges
Recursion Pharmaceuticals announced a 20% workforce reduction reflecting ongoing pipeline pruning and difficulties in securing capital given current biotech financing climates, signaling...
Insilico debuts Nach01 AI model to boost generative chemistry
Insilico Medicine launched its Nach01 foundation AI model via AWS Marketplace, enabling superior molecular prediction and retrosynthesis capabilities to accelerate drug discovery pipelines, making...
Merck’s RSV drug wins FDA nod amid vaccine panel upheaval
Merck & Co. secured FDA approval for Enflonsia (cesrovimab), a monoclonal antibody preventing respiratory syncytial virus in infants. This approval arrives amidst the unprecedented removal of the...
Concerns Over NIH Funding Cuts and Vaccine Advisory Disruptions
Amid severe changes including the termination of over $9 billion in NIH grants and dismissal of the CDC’s vaccine advisory committee (ACIP), hundreds of NIH scientists have issued the Bethesda...
Cutting-Edge Cancer Therapeutics and Research Models
Innovations in cancer therapy include Antares Therapeutics’ $177 million raise following its spinout from Scorpion Therapeutics and Nagoya University’s development of next-generation CAR-T cells...
Biotech Funding Climate: Record Series B and Funding Challenges
SpliceBio secured a $135 million Series B round to advance its dual AAV gene therapy candidate SB-007 for Stargardt disease despite a challenging funding environment. Meanwhile, National...
Advances in Stem Cell-Based Embryo Models and Sorting Technologies
The field of stem cell-based embryo models (SCBEM) is rapidly advancing, prompting updated ethical and regulatory oversight recommendations to ensure responsible research. In parallel, innovative...
Telehealth’s Breakthrough Role in Global Geriatric Cancer Care
A novel telehealth-driven supportive care program, GAIN-S, delivered personalized geriatric oncology interventions remotely, mitigating geographical and resource barriers in Brazil. The randomized...
Antimicrobial Resistance: Green Light-Activated Penicillin Innovation
Researchers developed a novel penicillin variant that remains inactive until triggered by green light, enabling precise spatial and temporal control over antibiotic activity. This...
Insmed Phase II Pulmonary Hypertension Data Spurs Stock Surge
Insmed's phase IIb trial of treprostinil palmitil inhalation powder (TPIP) for pulmonary arterial hypertension delivered a significant 35% placebo-adjusted reduction in pulmonary vascular...
AI and Big Data in Biotech R&D Acceleration
Artificial intelligence continues revolutionizing biotech R&D, with companies like Insilico Medicine unveiling advanced foundation models (Nach01) for generative chemistry applications, and...
Merck’s Pediatric RSV Approval Amid U.S. CDC Panel Shakeup
The U.S. FDA has approved Merck's monoclonal antibody Enflonsia (cesrovimab) to prevent respiratory syncytial virus lower respiratory tract disease in infants, positioning it as a competitor to...
Recursion Cuts 20% of Workforce Amid Restructuring and Funding Challenges
AI-driven drug discovery company Recursion Pharmaceuticals announced a 20% workforce reduction following strategic pipeline pruning and funding constraints faced amid biotech capital market...
Nanoparticle Vaccines Eradicate Pancreatic Cancer in Preclinical Trials
Innovative nanoparticle vaccine formulations targeting pancreatic ductal adenocarcinoma demonstrated remarkable efficacy in preclinical mouse models, achieving complete tumor clearance in over...